Nifty
:
24013.10
Sensex
:
76802.90
-154.90 (-0.64%)
-607.08 (-0.78%)
Nifty
Sensex
:
:
24013.10
76802.90
-154.90 (-0.64%)
-607.08 (-0.78%)

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :
66/99

BSE: 524494 | NSE: IPCALAB

NSE BSE
1585.80
19-Jun-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1551
  •  1609.1
  •  1542.5
  •  1543.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  262446
  •  417425479.6
  •  1678.3
  •  1251.6

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 40,189.29
  • 35.22
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 40,328.64
  • 0.38%
  • 4.98

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.72%
  • 0.33%
  • 5.79%
  • FII
  • DII
  • Others
  • 10.63%
  • 36.90%
  • 1.63%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.99
  • 10.52
  • 12.77

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.83
  • 2.43
  • 13.09

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.63
  • -8.40
  • 15.18

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 37.03
  • 43.10
  • 50.02

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.75
  • 4.75
  • 4.94

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.18
  • 20.70
  • 22.14

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
2,388.48
2,246.69
6.31%
2,392.50
2,245.37
6.55%
2,556.50
2,354.90
8.56%
2,308.85
2,092.63
10.33%
Expenses
1,904.61
1,817.83
4.77%
1,859.15
1,782.29
4.31%
2,011.58
1,913.42
5.13%
1,892.43
1,699.91
11.33%
EBITDA
483.87
428.86
12.83%
533.35
463.08
15.17%
544.92
441.48
23.43%
416.42
392.72
6.03%
EBIDTM
20.26%
19.09%
22.29%
20.62%
21.32%
18.75%
18.04%
18.77%
Other Income
93.74
25.82
263.05%
20.19
20.11
0.40%
27.86
26.26
6.09%
32.66
20.61
58.47%
Interest
20.20
21.51
-6.09%
17.62
16.81
4.82%
19.61
22.56
-13.08%
18.51
24.05
-23.04%
Depreciation
107.14
100.12
7.01%
107.59
98.46
9.27%
103.33
100.35
2.97%
100.06
98.89
1.18%
PBT
404.45
128.00
215.98%
445.98
367.92
21.22%
391.58
344.83
13.56%
330.51
290.39
13.82%
Tax
95.05
62.22
52.76%
81.93
90.59
-9.56%
108.08
99.39
8.74%
96.09
91.41
5.12%
PAT
309.40
65.78
370.36%
364.05
277.33
31.27%
283.50
245.44
15.51%
234.42
198.98
17.81%
PATM
12.95%
2.93%
15.22%
12.35%
11.09%
10.42%
10.15%
9.51%
EPS
11.79
2.67
341.57%
12.86
9.78
31.49%
11.14
9.05
23.09%
9.19
7.58
21.24%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
9,646.33
8,896.81
7,662.43
6,204.26
5,796.74
5,394.94
4,619.03
3,745.69
3,257.76
3,156.19
2,867.11
Net Sales Growth
7.91%
16.11%
23.50%
7.03%
7.45%
16.80%
23.32%
14.98%
3.22%
10.08%
 
Cost Of Goods Sold
2,822.72
2,444.61
2,251.73
2,079.50
1,790.78
1,547.98
1,455.41
1,090.34
978.34
939.40
903.04
Gross Profit
6,823.61
6,452.20
5,410.70
4,124.76
4,005.96
3,846.96
3,163.62
2,655.35
2,279.42
2,216.79
1,964.07
GP Margin
70.74%
72.52%
70.61%
66.48%
69.11%
71.31%
68.49%
70.89%
69.97%
70.24%
68.50%
Total Expenditure
7,667.77
7,226.28
6,398.38
5,300.99
4,539.12
3,913.71
3,728.56
3,067.42
2,815.78
2,740.77
2,593.42
Power & Fuel Cost
-
351.23
333.97
283.74
242.12
207.10
201.22
176.50
161.92
151.00
141.67
% Of Sales
-
3.95%
4.36%
4.57%
4.18%
3.84%
4.36%
4.71%
4.97%
4.78%
4.94%
Employee Cost
-
1,983.99
1,708.43
1,287.64
1,177.39
1,013.57
921.23
787.40
735.88
695.98
625.58
% Of Sales
-
22.30%
22.30%
20.75%
20.31%
18.79%
19.94%
21.02%
22.59%
22.05%
21.82%
Manufacturing Exp.
-
966.04
892.99
655.66
610.03
524.21
471.80
374.26
366.92
404.52
387.75
% Of Sales
-
10.86%
11.65%
10.57%
10.52%
9.72%
10.21%
9.99%
11.26%
12.82%
13.52%
General & Admin Exp.
-
387.39
345.05
296.10
261.34
242.22
249.90
271.85
268.52
246.68
219.87
% Of Sales
-
4.35%
4.50%
4.77%
4.51%
4.49%
5.41%
7.26%
8.24%
7.82%
7.67%
Selling & Distn. Exp.
-
917.41
745.87
595.47
402.81
324.86
359.15
317.84
277.62
280.74
249.22
% Of Sales
-
10.31%
9.73%
9.60%
6.95%
6.02%
7.78%
8.49%
8.52%
8.89%
8.69%
Miscellaneous Exp.
-
175.61
120.34
102.88
54.65
53.77
69.85
49.23
26.58
22.45
249.22
% Of Sales
-
1.97%
1.57%
1.66%
0.94%
1.00%
1.51%
1.31%
0.82%
0.71%
2.31%
EBITDA
1,978.56
1,670.53
1,264.05
903.27
1,257.62
1,481.23
890.47
678.27
441.98
415.42
273.69
EBITDA Margin
20.51%
18.78%
16.50%
14.56%
21.70%
27.46%
19.28%
18.11%
13.57%
13.16%
9.55%
Other Income
174.45
151.32
184.36
151.77
121.72
129.19
86.50
74.66
58.08
54.76
40.77
Interest
75.94
87.84
140.75
48.19
11.20
12.27
19.77
22.24
27.57
26.91
34.56
Depreciation
418.12
397.82
357.24
261.56
232.42
209.17
210.50
182.42
177.73
172.95
163.26
PBT
1,572.52
1,336.19
950.42
745.29
1,135.72
1,388.98
746.70
548.27
294.76
270.32
116.64
Tax
381.15
343.61
313.46
253.36
224.77
240.14
135.33
104.24
51.11
67.52
20.44
Tax Rate
24.24%
30.38%
37.20%
33.99%
19.79%
17.29%
18.12%
19.01%
17.34%
24.98%
17.52%
PAT
1,191.37
739.97
553.64
484.26
905.24
1,147.71
606.32
445.58
239.42
194.54
96.20
PAT before Minority Interest
1,148.71
787.53
529.21
491.93
910.95
1,148.84
603.56
442.22
239.42
194.54
96.20
Minority Interest
-42.66
-47.56
24.43
-7.67
-5.71
-1.13
2.76
3.36
0.00
0.00
0.00
PAT Margin
12.35%
8.32%
7.23%
7.81%
15.62%
21.27%
13.13%
11.90%
7.35%
6.16%
3.36%
PAT Growth
51.28%
33.66%
14.33%
-46.50%
-21.13%
89.29%
36.07%
86.11%
23.07%
102.22%
 
EPS
46.96
29.17
21.82
19.09
35.68
45.24
23.90
17.56
9.44
7.67
3.79

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
6,948.45
6,332.19
5,842.02
5,464.84
4,701.65
3,627.48
3,122.39
2,688.57
2,455.26
2,259.19
Share Capital
25.37
25.37
25.37
25.37
25.37
25.27
25.27
25.24
25.24
25.24
Total Reserves
6,920.38
6,305.21
5,816.65
5,439.47
4,676.28
3,590.27
3,097.12
2,663.01
2,430.02
2,233.95
Non-Current Liabilities
969.14
1,014.41
901.72
613.87
189.69
290.29
313.40
419.42
548.32
662.57
Secured Loans
543.24
580.41
651.78
395.18
9.13
88.80
133.94
234.01
347.22
433.63
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
14.17
6.91
0.00
4.52
50.64
Long Term Provisions
96.31
86.84
46.99
42.73
38.56
32.23
25.28
25.88
24.55
20.22
Current Liabilities
2,384.29
2,355.64
1,805.82
1,465.88
1,160.54
1,326.42
1,097.50
1,007.57
955.93
969.95
Trade Payables
846.17
776.08
525.06
557.70
664.86
609.85
524.32
423.47
396.54
421.11
Other Current Liabilities
725.45
732.62
488.15
420.52
204.49
304.57
274.74
266.75
316.41
297.50
Short Term Borrowings
495.25
559.24
661.82
367.81
176.61
310.95
209.69
239.04
177.30
184.85
Short Term Provisions
317.42
287.70
130.79
119.85
114.58
101.05
88.75
78.31
65.68
66.49
Total Liabilities
11,741.70
11,097.05
8,622.86
7,621.51
6,066.41
5,257.82
4,548.83
4,115.56
3,959.51
3,891.71
Net Block
4,266.81
4,553.53
2,751.38
2,402.19
2,072.43
2,058.73
1,940.38
1,952.96
1,983.27
2,014.18
Gross Block
6,994.56
7,020.79
4,353.42
3,749.46
3,201.39
2,985.73
2,632.86
2,464.33
2,318.22
2,176.95
Accumulated Depreciation
2,727.75
2,467.26
1,602.04
1,331.43
1,113.12
927.00
692.48
511.37
334.95
162.77
Non Current Assets
5,475.09
5,558.15
3,433.59
3,164.34
2,629.45
2,402.11
2,171.08
2,170.08
2,217.69
2,269.79
Capital Work in Progress
621.77
342.89
140.43
306.43
234.82
133.28
66.33
73.00
94.64
128.74
Non Current Investment
216.32
303.61
302.66
269.88
111.43
71.31
30.05
17.52
22.24
25.82
Long Term Loans & Adv.
317.29
315.59
229.61
169.63
185.64
127.61
128.36
119.37
106.07
85.14
Other Non Current Assets
52.90
42.53
9.51
16.21
25.13
11.18
5.96
7.23
11.47
15.91
Current Assets
5,967.04
5,535.55
5,189.27
4,446.71
3,436.96
2,855.71
2,377.75
1,945.48
1,741.81
1,621.92
Current Investments
763.39
558.40
323.32
719.31
393.83
238.25
90.38
69.35
113.57
0.00
Inventories
2,560.42
2,471.31
1,743.37
1,857.97
1,594.81
1,323.12
1,072.50
880.59
882.22
837.42
Sundry Debtors
1,873.82
1,686.51
989.02
910.78
811.75
895.20
681.51
602.27
500.16
445.87
Cash & Bank
344.23
296.84
1,853.24
640.66
365.07
180.92
282.30
150.57
35.85
175.54
Other Current Assets
425.18
325.01
124.70
116.19
271.50
218.22
251.06
242.70
210.01
163.09
Short Term Loans & Adv.
304.93
197.48
155.62
201.80
193.23
162.29
170.70
174.44
138.60
95.86
Net Current Assets
3,582.75
3,179.91
3,383.45
2,980.83
2,276.42
1,529.29
1,280.25
937.91
785.88
651.97
Total Assets
11,442.13
11,093.70
8,622.86
7,611.05
6,066.41
5,257.82
4,548.83
4,115.56
3,959.50
3,891.71

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
1,321.32
944.65
805.81
856.07
1,090.13
570.35
501.03
341.13
281.91
708.65
PBT
1,131.14
842.67
745.29
1,135.72
1,388.98
738.89
546.46
290.53
262.06
116.64
Adjustment
727.89
489.87
235.18
195.11
183.07
247.37
187.36
192.51
174.86
211.11
Changes in Working Capital
-176.46
-91.59
48.99
-272.72
-236.33
-263.69
-121.97
-84.44
-103.73
410.30
Cash after chg. in Working capital
1,682.57
1,240.95
1,029.46
1,058.11
1,335.72
722.57
611.85
398.60
333.19
738.05
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-361.25
-296.30
-223.65
-202.04
-245.59
-152.22
-110.82
-57.47
-51.28
-29.40
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-869.50
-1,291.79
-725.00
-855.05
-520.69
-509.65
-165.06
-135.40
-148.82
-218.33
Net Fixed Assets
-545.17
-329.13
-335.30
-597.37
-307.20
-284.34
-46.98
-60.09
-105.61
466.60
Net Investments
-39.10
-1,597.43
281.97
-470.86
-219.12
-326.48
-106.61
-4.05
-114.15
-15.57
Others
-285.23
634.77
-671.67
213.18
5.63
101.17
-11.47
-71.26
70.94
-669.36
Cash from Financing Activity
-282.98
-552.55
507.24
426.78
-305.82
-136.54
-183.20
-130.41
-159.13
-461.51
Net Cash Inflow / Outflow
168.84
-899.69
588.05
427.80
263.62
-75.84
152.77
75.32
-26.04
28.81
Opening Cash & Equivalents
755.79
1,578.98
990.93
559.01
295.39
370.92
218.15
142.83
168.87
140.06
Closing Cash & Equivalent
924.63
755.79
1,578.98
990.93
559.01
295.39
370.92
218.15
142.83
168.87

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
273.78
249.53
230.27
215.41
185.32
286.15
247.12
213.02
194.55
179.02
ROA
6.90%
5.37%
6.06%
13.31%
20.29%
12.47%
10.25%
6.03%
5.17%
2.50%
ROE
11.86%
8.70%
8.70%
17.92%
27.63%
18.15%
15.28%
9.47%
8.60%
4.31%
ROCE
15.27%
13.10%
11.71%
20.46%
30.92%
19.92%
16.53%
9.94%
9.44%
4.82%
Fixed Asset Turnover
1.28
1.35
1.54
1.68
1.75
1.65
1.48
1.37
1.43
1.23
Receivable days
72.68
63.37
55.52
53.92
57.48
61.90
62.09
61.27
53.75
50.16
Inventory Days
102.72
99.83
105.25
108.09
98.25
94.05
94.47
97.98
97.70
110.76
Payable days
121.11
102.19
86.04
111.16
136.39
49.85
51.13
50.35
52.23
52.92
Cash Conversion Cycle
54.30
61.01
74.74
50.86
19.34
106.10
105.43
108.90
99.22
108.00
Total Debt/Equity
0.19
0.22
0.25
0.14
0.05
0.13
0.15
0.23
0.29
0.38
Interest Cover
13.88
6.99
16.47
102.40
114.20
38.77
25.65
11.69
11.05
4.38

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Ipca Laboratories inks global licensing agreement with Bhami’s Research Laboratory
    15th Jun 2026, 14:10 PM

    The company has been granted access to BRL's proprietary high-concentration subcutaneous biologics delivery platform

    Read More
  • Ipca Laboratories - Quarterly Results
    30th May 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.